J&J says may not close Guidant deal
2nd Nov 2005, 17:35 GMT
J&J said it may not complete its $25.4 bln purchase of Guidant, saying the recall of products at the medical device maker had hurt the value of the company.
J&J says may not close Guidant deal related news:
- JVamp;J threatens to drop its deal for Guidant — Business - International Herald Tribune
- Johnson & Johnson says it might not complete Guidant deal — Breaking Business (AP)
- J&J threatens to back out of Guidant deal — FT.com / Home US
- J & J says Guidant deal on hold — United Press International - NewsTrack
- J&J Presses Guidant on Takeover Price — WSJ.com: What's News US
- J&J-Guidant Deal Teetering — Health News: CBSnews.com
- Johnson & Johnson May Nix Guidant Deal — NBC 17 - Money
- J&J looks to renegotiate troubled Guidant deal — MarketWatch.com - Top Stories
- J&J May Not Complete $25.4B Guidant Deal (AP) — Yahoo! News: Top Stories
- J&J May Not Complete $25.4B Guidant Deal — AP Top Headlines At 2:09 p.m. EST
Latest news from Financial News News from StratCenter.com:
- TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
- Bio-Rad Closes Buy of Ciphergen Unit
- The LGL Group Reports Q3 Earnings
- Analogic CEO to retire
- Analogic CEO Plans to Retire
- Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
- JMAR Receives Nasdaq Delisting Notice
- Analogic Corp Announces Mgmt Changes
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
- Agilent to buy Switzerland's Acqiris